Abstract
Cancer, which accounted for 7.9 million deaths (around 13% of all deaths) in 2007, is a leading cause of death in the world. Deaths from cancer worldwide are projected to continue rising, with an estimated 12 million deaths in 2030. Therefore, the rapid increase in the cancer burden represents a real crisis for public health and health systems worldwide. Although cancer chemotherapy will cause side effects and drug resistance, it is still recognized as the first choice for the treatment of many cancers. To our knowledge, naphthalimide (1H-benzo[de]isoquinoline-1,3-(2H)-dione) analogs have been considered as one promising and potential class of anticancer agents against human tumor cells, such as amonafide (Quinamed®) was the first naphthalimide analog that reached the clinical trial stage and exhibited excellent antitumour activity against advanced breast cancer. In this review, we make attempts to report recent advances on the synthesis of naphthalimide analogs, including mononaphthalimides, bisnaphthalimides, and naphthalimide-other heterocycles conjugates; in the meantime, the relationships between the structures of the naphthalimides and the antitumour activity are investigated in detail. It will pave the way for the design and development of naphthalimide analogs as anticancer agents.
Keywords: Naphthalimide, mononaphthalimide, bisnaphthalimide, synthesis, anticancer, chemotherapy, mechanism of action, structure-activity relationship
Current Medicinal Chemistry
Title: Overview of Naphthalimide Analogs as Anticancer Agents
Volume: 16 Issue: 36
Author(s): Min Lv and Hui Xu
Affiliation:
Keywords: Naphthalimide, mononaphthalimide, bisnaphthalimide, synthesis, anticancer, chemotherapy, mechanism of action, structure-activity relationship
Abstract: Cancer, which accounted for 7.9 million deaths (around 13% of all deaths) in 2007, is a leading cause of death in the world. Deaths from cancer worldwide are projected to continue rising, with an estimated 12 million deaths in 2030. Therefore, the rapid increase in the cancer burden represents a real crisis for public health and health systems worldwide. Although cancer chemotherapy will cause side effects and drug resistance, it is still recognized as the first choice for the treatment of many cancers. To our knowledge, naphthalimide (1H-benzo[de]isoquinoline-1,3-(2H)-dione) analogs have been considered as one promising and potential class of anticancer agents against human tumor cells, such as amonafide (Quinamed®) was the first naphthalimide analog that reached the clinical trial stage and exhibited excellent antitumour activity against advanced breast cancer. In this review, we make attempts to report recent advances on the synthesis of naphthalimide analogs, including mononaphthalimides, bisnaphthalimides, and naphthalimide-other heterocycles conjugates; in the meantime, the relationships between the structures of the naphthalimides and the antitumour activity are investigated in detail. It will pave the way for the design and development of naphthalimide analogs as anticancer agents.
Export Options
About this article
Cite this article as:
Lv Min and Xu Hui, Overview of Naphthalimide Analogs as Anticancer Agents, Current Medicinal Chemistry 2009; 16 (36) . https://dx.doi.org/10.2174/092986709789909576
DOI https://dx.doi.org/10.2174/092986709789909576 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
CC Chemokine Receptor Small Molecule Antagonists in the Treatment of Rheumatoid Arthritis and Other Diseases: A Current View
Current Topics in Medicinal Chemistry 21-Hydroxy-6,19-epoxyprogesterone: A Promising Therapeutic Agent and a Molecular Tool for Deciphering Glucocorticoid Action
Mini-Reviews in Medicinal Chemistry Genomic and Epigenomic Instability, Fragile Sites, Schizophrenia and Autism
Current Genomics An In silico Approach for Identification of Novel Inhibitors as a Potential Therapeutics Targeting HIV-1 Viral Infectivity Factor
Current Topics in Medicinal Chemistry Objective Biomarkers or Symptom Scores for the Classification of Fibromyalgia Syndrome?
Current Rheumatology Reviews Outline of Proteins and Signaling Pathways Involved in Heart Failure
Current Protein & Peptide Science Novel Insights Into the Role of MicroRNA in Lung Cancer Resistance to Treatment and Targeted Therapy
Current Cancer Drug Targets Breast Reconstruction – A Historical Perspective on Available Techniques for Patients Electing Bilateral Mastectomy
Current Cancer Therapy Reviews Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease
Current Alzheimer Research Recent Advances in Liposome Techniques and their Applications in Arthritis
Recent Patents on Biomedical Engineering (Discontinued) Cigarette Smoke Decreases Salivary 18 kDa Translocator Protein Binding Affinity – in Association with Oxidative Stress
Current Medicinal Chemistry Topics of Physiological and Pathophysiological Functions of Lymphatics
Current Molecular Medicine Suicide Gene Therapy Against Malignant Gliomas by the Local Delivery of Genetically Engineered Umbilical Cord Mesenchymal Stem Cells as Cellular Vehicles
Current Gene Therapy Targeting the Epidermal Growth Factor Pathway as Therapy for Glioblastoma
Current Cancer Therapy Reviews Bilski: Assessing the Impact of a Newly Invigorated Patent-Eligibility Doctrine on the Pharmaceutical Industry and the Future of Personalized Medicine
Current Topics in Medicinal Chemistry Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer
Reviews on Recent Clinical Trials Hypoxia Inducible Factor-1 in Cancer Immune Suppression
Current Immunology Reviews (Discontinued) Targeted Cancer Therapy: The Next Generation of Cancer Treatment
Current Drug Discovery Technologies From Nonsteroidal Aromatase Inhibitors to Multifunctional Drug Candidates: Classic and Innovative Strategies for the Treatment of Breast Cancer
Current Topics in Medicinal Chemistry Novel Agents Targeting Bioactive Sphingolipids for the Treatment of Cancer
Current Medicinal Chemistry